New research: alphaH® offers New Assistance to smokers that aspires to counteract the damaging effects of smoking.
“In HG Pharma we have spent considerable scientific resources and our best effort into developing the new alphaH®substance, to counteract the damaging effects of oxidative stress in the human body, thus we are naturally delighted to be able to have new scientific research confirm the counteractive effects of alphaH® in respect to heavy smoking” says Prof. Priv. Doz. Dr. med. Ralf Herwig, Scientist of HG Pharma GmbH.
“Smoking is damaging because it causes increased oxidative stress in the body. The effect of oxidative stress is just like when an apple turns brown when exposed to air, our cells can “oxidize”, a process caused by free radicals. In short free radicals are unstable molecules that damage cells by oxidizing throughout the body. The process is called oxidative stress. Exposure to cigarette smoke increases the formation of oxidatively modified proteins, lipids, DNA/RNA and carbohydrates in humans. These modified toxic substances are involved in several pathologies (diseases) such as e.g., cancer. Anti-oxidative dietary supplementation is known to decrease the formation of these oxidatively modified proteins, also called, carbonyl proteins. At HG Pharma, we just wanted to innovate on this biologic effect and enhance it to a regular biologic medical supplemental therapy to reduce the damaging effects of oxidative stress and its related diseases.
– We are now pleased that the results of the scientific study were very positive: In summary, the research shows, that a high protective effect of anti-oxidative substances, as combined in alphaH®, against free radical production from cigarette smoke can be reached in vitro and in vivo – and implies that future studies investigating the protective effect of antioxidant consumption on several disorders should also consider smoking status”.
HG Pharma will be commercially introducing alphaH®as a Medically Dietary Supplement; the alphaH2+®, this will be available by end of August 2018.
Read More about alphaH®
For further information please contact:
HG Pharma GmbH
Please read more in the Press Release from HG Pharma GmbH, Vienna 5thof June 2018.